258
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Manifestation of Borderline Personality Symptomatology in Chronic Pain Patients Under Stress: An Understated and Exacerbated Consequence of the COVID-19 Crisis

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1431-1439 | Published online: 15 Jun 2020

References

  • Giordano J, Schatman ME. An ethical analysis of crisis in chronic pain care. Part 1. Facts, issues, and problems in pain medicine. Pain Physician. 2008;11:483–490.
  • Schatman ME, Lebovits AH. On the transformation of the “profession” of pain medicine to the “business” of pain medicine: an introduction to a special series. Pain Med. 2011;12(3):403–405. doi:10.1111/j.1526-4637.2011.01059.x
  • Schatman ME, Webster LR. The health insurance industry: perpetuating the opioid crisis through policies of cost-containment and profitability. J Pain Res. 2015;8:153–158. doi:10.2147/JPR.S83368
  • Fudin J, Pratt Cleary J, Schatman ME. The MEDD myth: the impact of pseudoscience on pain research and prescribing guideline development. J Pain Res. 2016;9:153–156. doi:10.2147/JPR.S107794
  • Loeser JD, Schatman ME. Chronic pain management in medical education: a disastrous omission. Postgrad Med. 2017;129(3):332–335. doi:10.1080/00325481.2017.1297668
  • Keppel Hesselink J, Schatman M. “But that is your opinion”: the dark side of postmodern pain medicine creating a postmodern patient autonomy. J Pain Res. 2018;11:2847–2851. doi:10.2147/JPR.S188618
  • Singer JA, Sullum JZ, Schatman ME. Today’s nonmedical opioid users are not yesterday’s patients: implications of data indicating stable rates of nonmedical and pain reliever use disorder. J Pain Res. 2019;12:617–620. doi:10.2147/JPR.S199750
  • Lo Bianco G, Thomson S, Vigneri S, Shapiro H, Schatman ME. Abdominal epilepsy, a rare cause of abdominal pain: the need to investigate thoroughly as opposed to making rapid attributions of psychogenic causality. J Pain Res. 2020;13:457–460. doi:10.2147/JPR.S247767
  • Ilgen MA, Bohnert ASB, Ganoczy D, Bair MJ, McCarthy JF, Blow FC. Opioid dose and risk of suicide. Pain. 2016;157(5):1079–1084. doi:10.1097/j.pain.0000000000000484
  • Oquendo MA, Volkow ND. Suicide: a silent contributor to opioid overdose deaths. N Engl J Med. 2018;378(17):1567–1569. doi:10.1056/NEJMp1801417
  • Perez HR, Buonora M, Cunningham CO, Heo M, Starrels JL. Opioid taper is associated with subsequent termination of care: a retrospective cohort study. J Gen Intern Med. 2020;35(1):36–42. doi:10.1007/s11606-019-05227-9
  • Lembke A. Tapering long-term opioid therapy. Am Fam Physician. 2020;101(1):49–52.
  • Means-Christensen AJ, Roy-Byrne PP, Sherbourne CD, Craske MG, Stein MB. Relationships among pain, anxiety, and depression in primary care. Depress Anxiety. 2008;25(7):593–600. doi:10.1002/da.20342
  • Tajerian M, Leu D, Zou Y, et al. Brain neuroplastic changes accompany anxiety and memory deficits in a model of complex regional pain syndrome. Anesthesiology. 2014;121(4):852–865. doi:10.1097/ALN.0000000000000403
  • Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13(2):116–137. doi:10.1097/00002508-199706000-00006
  • Gureje O, Von Korff M, Kola L, et al. The relation between multiple pains and mental disorders: results from the World Mental Health Surveys. Pain. 2008;135(1–2):82–91. doi:10.1016/j.pain.2007.05.005
  • Kroenke K, Wu J, Bair MJ, Krebs EE, Damush TM, Tu W. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain. 2011;12:964–973. doi:10.1016/j.jpain.2011.03.003
  • Gureje O. Comorbidity of pain and anxiety disorders. Curr Psychiatry Rep. 2008;10(4):318–322. doi:10.1007/s11920-008-0051-0
  • Arola HM, Nicholls E, Mallen C, Thomas E. Self-reported pain interference and symptoms of anxiety and depression in community-dwelling older adults: can a temporal relationship be determined? Eur J Pain. 2010;14(9):966–971. doi:10.1016/j.ejpain.2010.02.012
  • Robb LP, Cooney JM, McCrory CR. Evaluation of spinal cord stimulation on the symptoms of anxiety and depression and pain intensity in patients with failed back surgery syndrome. Ir J Med Sci. 2017;186(3):767–771. doi:10.1007/s11845-017-1565-4
  • Large RG. The psychiatrist and the chronic pain patient: 172 anecdotes. Pain. 1980;9(2):253–263. doi:10.1016/0304-3959(80)90012-3
  • Large RG. DSM-III diagnoses in chronic pain. Confusion or clarity? J Nerv Ment Dis. 1986;174(5):295–303. doi:10.1097/00005053-198605000-00006
  • Reich J, Tupin JP, Abramowitz SI. Psychiatric diagnosis of chronic pain patients. Am J Psychiatry. 1983;140(11):1495–1498.
  • Fishbain DA, Goldberg M, Meagher BR, Steele R, Rosomoff H. Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain. 1986;26(2):181–197. doi:10.1016/0304-3959(86)90074-6
  • Gatchel RJ, Polatin PB, Kinney RK. Predicting outcome of chronic back pain using clinical predictors of psychopathology: a prospective analysis. Health Psychol. 1995;14(5):415–420. doi:10.1037/0278-6133.14.5.415
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
  • Elliott TR, Jackson WT, Layfield M, Kendall D. Personality disorders and response to outpatient treatment of chronic pain. J Clin Psychol Med Settings. 1996;3(3):219–234. doi:10.1007/BF01993908
  • Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007;62(6):553–564. doi:10.1016/j.biopsych.2006.09.019
  • Frankenburg FR, Zanarini MC. The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry. 2004;65(12):1660–1665. doi:10.4088/JCP.v65n1211
  • Alciati A, Sarzi-Puttini P, Batticciotto A, et al. Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorder. Clin Exp Rheumatol. 2012;30(6 Suppl 74):122–128.
  • Sansone RA, Sansone LA. Borderline personality disorder in the medical setting: suggestive behaviors, syndromes, and diagnoses. Innov Clin Neurosci. 2015;12(7–8):39–44.
  • Sansone RA, Sansone LA. Borderline personality in the medical setting. Prim Care Companion CNS Disord. 2015;17(3). doi:10.4088/PCC.14r01743
  • Sansone RA, Sansone LA. Borderline personality and the pain paradox. Psychiatry (Edgmont). 2007;4(4):40–46.
  • Reynolds CJ, Carpenter RW, Tragesser SL. Accounting for the association between BPD features and chronic pain complaints in a pain patient sample: the role of emotion dysregulation factors. Personal Disord. 2018;9(3):284–289. doi:10.1037/per0000237
  • Biskin RS, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Pain in patients with borderline personality disorder. Personal Ment Health. 2014;8(3):218–227. doi:10.1002/pmh.1265
  • Tragesser SL, Jones RE, Robinson RJ, Stutler A, Stewart A. Borderline personality disorder features and risk for prescription opioid use disorders. J Pers Disord. 2013;27(4):427–441. doi:10.1521/pedi_2013_27_094
  • Dulit RA, Fyer MR, Haas GL, et al. Substance use in borderline personality disorder. Am J Psychiatry. 1990;147:1002–1007.
  • Sansone RA, Watts DA, Wiederman MW. The misuse of prescription pain medication and borderline personality symptomatology. J Opioid Manag. 2013;9(4):275–279. doi:10.5055/jom.2013.0169
  • Feely MA, Havyer RD, Lapid MI, Swetz KM. Management of end-of-life care and of difficult behaviors associated with borderline personality disorder. J Pain Symptom Manage. 2013;45(5):934–938. doi:10.1016/j.jpainsymman.2012.04.004
  • Reynolds CJ, Vest N, Tragesser SL. Borderline personality disorder features and risk for prescription opioid misuse in a chronic pain sample: roles for identity disturbances and impulsivity. J Pers Disord. 2019;1–18. doi:10.1521/pedi_2019_33_440
  • Sansone RA, Sansone LA. Chronic pain syndromes and borderline personality. Innov Clin Neurosci. 2012;9(1):10–14.
  • Kalira V, Treisman GJ, Clark MR. Borderline personality disorder and chronic pain: a practical approach to evaluation and treatment. Curr Pain Headache Rep. 2013;17(8):350. doi:10.1007/s11916-013-0350-y
  • Soloff PH, Lynch KG, Kelly TM, Malone KM, Mann JJ. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. Am J Psychiatry. 2000;157(4):601–608. doi:10.1176/appi.ajp.157.4.601
  • Brown MZ, Comtois KA, Linehan MM. Reasons for suicide attempts and nonsuicidal self-injury in women with borderline personality disorder. J Abnorm Psychol. 2002;111(1):198–202. doi:10.1037/0021-843X.111.1.198
  • Paris J, Zweig-Frank H. A 27-year follow-up of patients with borderline personality disorder. Compr Psychiatry. 2001;42(6):482–487. doi:10.1053/comp.2001.26271
  • Paris J. Suicidality in borderline personality disorder. Medicina (Kaunas). 2019;55(6):E223.ff. doi:10.3390/medicina55060223
  • Tang NK, Crane C. Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links. Psychol Med. 2006;36(5):575–586. doi:10.1017/S0033291705006859
  • Braden JB, Sullivan MD. Suicidal thoughts and behavior among adults with self-reported pain conditions in the national comorbidity survey replication. J Pain. 2008;9(12):1106–1115. doi:10.1016/j.jpain.2008.06.004
  • Campbell G, Bruno R, Darke S, Degenhardt L. Associations of borderline personality with pain, problems with medications and suicidality in a community sample of chronic non-cancer pain patients prescribed opioids for pain. Gen Hosp Psychiatry. 2015;37(5):434–440. doi:10.1016/j.genhosppsych.2015.05.004
  • Burton K, Polatin PB, Gatchel RJ. Psychosocial factors and the rehabilitation of patients with chronic work-related upper extremity disorders. J Occup Rehabil. 1997;7(3):139–153. doi:10.1007/BF02767360
  • Sansone RA, Hruschka J, Vasudevan A, Miller SN. Disability and borderline personality symptoms. Psychosomatics. 2003;44(5):442. doi:10.1176/appi.psy.44.5.442
  • Knudsen AK, Skogen JC, Harvey SB, et al. Personality disorders, common mental disorders and receipt of disability benefits: evidence from the British National Survey of Psychiatric Morbidity. Psychol Med. 2012;42(12):2631–2640. doi:10.1017/S0033291712000906
  • Østby KA, Czajkowski N, Knudsen GP, et al. Personality disorders are important risk factors for disability pensioning. Soc Psychiatry Psychiatr Epidemiol. 2014;49(12):2003–2011. doi:10.1007/s00127-014-0878-0
  • Reynolds CJ, Tragesser SL. Borderline personality disorder features are associated with concurrent pain-related disability in a chronic pain sample. Pain Med. 2019;20(2):233–245. doi:10.1093/pm/pny052
  • Crowell SE, Beauchaine TP, Linehan MM. A biosocial developmental model of borderline personality: elaborating and extending Linehan’s theory. Psychol Bull. 2009;135(3):495–510. doi:10.1037/a0015616
  • Perez-Rodriguez MM, Bulbena-Cabré A, Bassir Nia A, Zipursky G, Goodman M, New AS. The neurobiology of borderline personality disorder. Psychiatr Clin North Am. 2018;41(4):633–650. doi:10.1016/j.psc.2018.07.012
  • Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York: Guilford Press; 1993.
  • Ryan RM. The developmental line of autonomy in the etiology, dynamics, and treatment of borderline personality disorders. Dev Psychopathol. 2005;17(4):987–1006. doi:10.1017/S0954579405050467
  • Skodol AE. The borderline diagnosis: concepts, criteria, and controversies. In: Gunderson JG, Hoffman PD, editors. Understanding and Treating Borderline Personality Disorder a Guide for Professionals and Families. Washington, DC: American Psychiatric Publishing, Inc.; 2005:3–19.
  • Gunderson JG, Lyons-Ruth K. The developmental line of autonomy in the etiology, dynamics, and treatment of borderline personality disorders. Dev Psychopathol. 2008;17(4):987–1006.
  • Flor H, Turk DC. Etiological theories and treatments for chronic back pain. I. Somatic models and interventions. Pain. 1984;19(2):105–121.
  • Turk DC, Flor H. Etiological theories and treatments for chronic back pain. II. Psychological models and interventions. Pain. 1984;19(3):209–233.
  • Weisberg JN, Keefe FJ. Personality, individual differences, and psychopathology in chronic pain. In: Gatchel RJ, Turk DC, editors. Psychosocial Factors in Pain: Critical Perspectives. New York: The Guilford Press; 1999:56–73.
  • Weisberg JN, Keefe FJ. Personality disorders in the chronic pain population: basic concepts, empirical findings, and clinical implications. Pain Forum. 1997;6:1–9. doi:10.1016/S1082-3174(97)70001-1
  • Weisberg JN. Personality and personality disorders in chronic pain. Curr Rev Pain. 2000;4(1):60–70. doi:10.1007/s11916-000-0011-9
  • Weisberg JN, Vittengl JR, Clark LA, Gatchel RJ, Gorin AA. Personality and pain: summary and future perspectives. In: Gatchel RJ, Weisberg JN, editors. Personality Characteristics of Patients with Pain. Washington, DC: American Psychological Association; 2000:259–282.
  • Lumley MA, Cohen JL, Borszcz GS, et al. Pain and emotion: a biopsychosocial review of recent research. J Clin Psychol. 2011;67(9):942–968. doi:10.1002/jclp.20816
  • Ahmad AH, Zakaria R. Pain in times of stress. Malays J Med Sci. 2015;22(SpecIssue):52–61.
  • Vachon-Presseau E. Effects of stress on the corticolimbic system: implications for chronic pain. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87(Pt B):216–223. doi:10.1016/j.pnpbp.2017.10.014
  • Eccleston C, Blyth FM, Dear BF, et al. Managing patients with chronic pain during the COVID-19 outbreak: considerations for the rapid introduction of remotely supported (eHealth) pain management services. Pain. 2020;161(5):889–893. doi:10.1097/j.pain.0000000000001885
  • Cohen SP, Baber ZB, Buvanendran A, et al. Pain management best practices from multispecialty organizations during the COVID-19 pandemic and public health crises. Pain Med. 2020;pii:pnaa127. doi:10.1093/pm/pnaa127
  • Brunero S, The LS. ‘difficult’ nurse-patient relationship: development and evaluation of an e-learning package. Contemp Nurse. 2010;35(2):136–146. doi:10.5172/conu.2010.35.2.136
  • Kyratsous M, Sanati A. Epistemic injustice and responsibility in borderline personality disorder. J Eval Clin Pract. 2017;23(5):974–980. doi:10.1111/jep.12609
  • Knaak S, Mantler E, Szeto A. Mental illness-related stigma in healthcare: barriers to access and care and evidence-based solutions. Healthc Manage Forum. 2017;30(2):111–116. doi:10.1177/0840470416679413
  • van Rijswijk SM, van Beek MHCT, Schoof GM, Schene AH, Steegers M, Schellekens AF. Iatrogenic opioid use disorder, chronic pain and psychiatric comorbidity: a systematic review. Gen Hosp Psychiatry. 2019;59:37–50. doi:10.1016/j.genhosppsych.2019.04.008
  • Harris AB, Marrache M, Puvanesarajah V, et al. Are preoperative depression and anxiety associated with patient-reported outcomes, health care payments, and opioid use after anterior discectomy and fusion? Spine J. 2020: S1529-9430(20)30096. doi:10.1016/j.spinee.2020.03.004.
  • Shepherd HL, Geerligs L, Butow P, et al. The elusive search for success: defining and measuring implementation outcomes in a real-world hospital trial. Front Public Health. 2019;7:293. doi:10.3389/fpubh.2019.00293
  • Larvin H, Peckham E, Prady SL. Case-finding for common mental disorders in primary care using routinely collected data: a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2019;54(10):1161–1175. doi:10.1007/s00127-019-01744-4
  • Rajesh R, Tampi R, Balachandran S. The case for behavioral health integration into primary care. J Fam Pract. 2019;68(5):278–284.
  • Jha MK, Grannemann BD, Trombello JM, et al. A structured approach to detecting and treating depression in primary care: vitalSign6 Project. Ann Fam Med. 2019;17(4):326–335. doi:10.1370/afm.2418
  • DiBenedetto DJ, Wawrzyniak KM, Schatman ME, Shapiro H, Kulich RJ. Increased frequency of urine drug testing in chronic opioid therapy: rationale for strategies for enhancing patient adherence and safety. J Pain Res. 2019;12:2239–2246. doi:10.2147/JPR.S213536
  • Stone AH, MacDonald JH, King PJ. The effect of psychiatric diagnosis and psychotropic medication on outcomes following total hip and total knee arthroplasty. J Arthroplasty. 2019;34(9):1918–1921. doi:10.1016/j.arth.2019.04.064
  • Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord. 2003;17(6):568–573. doi:10.1521/pedi.17.6.568.25355
  • Zimmerman M, Balling C. Screening for borderline personality disorder with the McLean Screening Instrument: a review and critique of the literature. J Pers Disord. 2019;1–11. doi:10.1521/pedi_2019_33_451
  • Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. Pain Physician. 2017;20(2S):S93–S109. doi:10.36076/ppj.2017.s111
  • Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 2. Pain Physician. 2017;20(2S):S111–S133.
  • Vaughn IA, Beyth R, Ayers ML, et al. Multispecialty opioid risk reduction program targeting chronic pain and addiction management in veterans. Fed Pract. 2019;36(9):406–411.